Neo Ivy Capital Management’s Agilon Health AGL Stock Holding History

Neo Ivy Capital Management’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-6,153	Closed	-$1.01M	–	267
2024 Q2	$1.01M	Buy	+6,153	New	+$877K	0.2%	140
2023 Q4	$47K	Buy	+150	New	+$54.3K	0.11%	175
2023 Q3	–	Sell	-12	Closed	-$5K	–	316
2023 Q2	$5K	Buy	+12	New	+$6.74K	﹤0.01%	273
2022 Q4	$406K	Buy	+1,005	New	+$471K	0.27%	174
2022 Q3	–	Hold	0	–	–	–	373
2021 Q3	–	Sell	-76	Closed	-$77K	–	446
2021 Q2	$77K	Buy	+76	New	+$66.6K	0.08%	277

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Neo Ivy Capital Management's AGL Position: Q3 2024 in Review

Neo Ivy Capital Management sold out of Agilon Health (AGL) in Q3 2024, closing a stake of 6,153 shares — an estimated $1.01M sold.

Neo Ivy Capital Management first reported a position in AGL in Q2 2021 and held it in 5 quarters. The position peaked at $1.01M in Q2 2024. 209 funds tracked by Wall St. Rank hold AGL as of Q3 2024.

Neo Ivy Capital Management reported no remaining Agilon Health position as of Q3 2024 after selling out during the quarter.
Neo Ivy Capital Management sold 6,153 Agilon Health shares in Q3 2024, an estimated $1.01M.
Neo Ivy Capital Management first reported a position in Agilon Health in Q2 2021 and held it in 5 quarters.
Neo Ivy Capital Management's Agilon Health position peaked at $1.01M in Q2 2024.
209 funds tracked by Wall St. Rank held Agilon Health as of Q3 2024.

Based on Neo Ivy Capital Management's 13F filing for Q3 2024, filed 18 Nov 2024.